Trademark applications and grants for Seqirus Uk L T D. Seqirus Uk L T D has 121 trademark applications. The latest application filed is for "FLUAD INFLUENZA VACCINE, ADJUVANTED"
Patent Application | Date |
---|---|
ADJUVANTED MULTIVALENT INFLUENZA VACCINES 20220168413 - 17/432986 CIARLET; Max ;   et al. | 2022-06-02 |
PREPARATION OF INFLUENZA VIRUS VACCINE ANTIGENS 20210205438 - 17/151840 HAUSSMANN; Christoph ;   et al. | 2021-07-08 |
ADJUVANTED VACCINES WITH NON-VIRION ANTIGENS PREPARED FROM INFLUENZA VIRUSES GROWN IN CELL CULTURE 20210170021 - 17/072136 RAPPUOLI; Rino ;   et al. | 2021-06-10 |
CELL-DERIVED VIRAL VACCINES WITH LOW LEVELS OF RESIDUAL CELL DNA 20200377864 - 16/843940 GREGERSEN; Jens-Peter ;   et al. | 2020-12-03 |
VACCINATION OF IMMUNOCOMPROMISED SUBJECTS 20200306365 - 16/901185 DEL GIUDICE; Giuseppe ;   et al. | 2020-10-01 |
NCAGE Code | U1P33 | SEQIRUS UK LIMITED |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.